ArticleFrontiers in immunology2022

Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment.

Laura Thümmler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.